Blog
Trial design: 4 ways to improve trials of pro-cognitive drugs in schizophrenia
Discussing the methodological considerations, and suggesting recommendations, for successful pro-cognitive drugs trials in schizophrenia.
web-based testing,
wearables,
voice recognition,
voice,
virtual clinical trials,
technology,
swm,
subjective measures,
stress,
social cognition,
smartphones,
schizophrenia,
safety,
rvp,
rti,
research funding,
research,
remote testing,
recruitment,
psychosis,
prodromal,
pro-cognitive,
prm,
press release,
presenteeism,
precision psychiatry,
poster,
personalised medicine,
patient-centric,
patient recruitment,
parkinson's disease,
pal,
ots,
occupational health,
objective measures,
normative data,
neuroscience,
near-patient testing,
multiple sclerosis,
mts,
ms,
mental wellbeing,
mental health at work,
mental health,
mdd,
mci,
major depression,
machine learning,
longitudinal,
life at cambridge cognition,
international women's day,
hot cognition,
healthcare,
grant,
funding,
fatigue,
ert,
epidemiology,
ecoa,
ebt,
early career researchers,
early alzheimer's disease,
dms,
digital tools,
digital health,
depression,
dementia,
covid-19,
cognitive wellbeing,
cognitive testing,
cognitive science,
cognitive safety,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive deficits,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
clinical trial,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab,
cambridge cognition careers,
cambridge cognition,
brain health,
bipolar disorder,
biomarkers,
automatic speech recognition,
attention,
alzheimer's disease,
academic,
absenteeism,
